Understanding Adverse Effects of CAR T-Cell Therapies

This chapter examines the side effects of CAR T-cell therapies, emphasizing cytokine release syndrome (CRS) and neurological toxicities linked to anti-CD19 treatments. It also addresses less common but serious effects associated with anti-BCMA CAR T cells, underscoring their importance in patient management after infusion.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.